| 12414948 |
Methods |
Sophie DUTHEIL, Gretchen SNYDER, Peng Li |
2025-09-16 |
|
| 12409176 |
Methods of treating acute depression |
Gretchen SNYDER, Lawrence P. Wennogle |
2025-09-09 |
|
| 12410195 |
Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders |
Peng Li, Kimberly VANOVER |
2025-09-09 |
|
| 12410175 |
Compounds |
Peng Li |
2025-09-09 |
|
| 12396992 |
Organic compounds |
Gretchen SNYDER, Lawrence P. Wennogle, Jennifer O'BRIEN, Joseph Hendrick |
2025-08-26 |
|
| 12364695 |
Methods of treating inflammatory disease |
Peng Li |
2025-07-22 |
|
| 12364694 |
Organic compounds |
Peng Li, Qiang Zhang |
2025-07-22 |
|
| 12336989 |
Transmucosal methods for treating psychiatric and neurological conditions |
Peng Li, Wei Yao |
2025-06-24 |
|
| 12325726 |
Organic compounds |
Kimberly VANOVER, Peng Li, Yupu QIAO |
2025-06-10 |
|
| 12268686 |
Transmucosal methods for treating psychiatric and neurological conditions |
Peng Li, Wei Yao |
2025-04-08 |
|
| 12269825 |
Organic compounds |
Sharon Mates, Peng Li, Lawrence P. Wennogle |
2025-04-08 |
|
| 12264160 |
Pharmaceutical compositions comprising 4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-one for treating central nervous system disorders |
Peng Li, Qiang Zhang, Lawrence P. Wennogle |
2025-04-01 |
|
| 12240850 |
Pharmaceutical compositions comprising 4-((6bR, 10aS)-3-methyl-2,3,6b,9,10, 10a-hexahydro-1H,7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-ol for treating central nervous system disorders |
Peng Li, Qiang Zhang, Lawrence P. Wennogle |
2025-03-04 |
|
| 12215578 |
Integrated perforating gun and setting tool system and method |
Terrell Saltarelli, Jason Ansley |
2025-02-04 |
|
| 12195463 |
Organic compounds |
Peng Li, Kimberly VANOVER |
2025-01-14 |
|
| 12195462 |
Organic compound |
Peng Li, Qiang Zhang |
2025-01-14 |
|
| 12194042 |
Uses |
Kimberly VANOVER |
2025-01-14 |
|
| 12173004 |
Pharmaceutical compositions comprising heterocycle fused gamma carboline prodrugs |
Peng Li, Hailin Zheng, Sharon Mates, Kimberly VANOVER, Gretchen SNYDER |
2024-12-24 |
$87,681,000 |
| 12144808 |
Compositions and methods |
Peng Li |
2024-11-19 |
$89,022,000 |
| 12128043 |
Pharmaceutical capsules comprising lumateperone mono-tosylate |
Peng Li |
2024-10-29 |
$93,375,000 |
| 12122792 |
Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders |
Peng Li, Kimberly VANOVER |
2024-10-22 |
$78,680,000 |
| 12090155 |
Methods |
Sharon Mates, Kimberly VANOVER |
2024-09-17 |
$79,269,000 |
| 12070459 |
Pharmaceutical capsule compositions comprising lumateperone mono-tosylate |
Peng Li |
2024-08-27 |
$75,740,000 |
| 12023331 |
Methods |
Gretchen SNYDER, Lawrence P. Wennogle |
2024-07-02 |
$70,351,000 |
| 11980617 |
Methods of treating acute depression and/or acute anxiety |
Gretchen SNYDER, Lawrence P. Wennogle |
2024-05-14 |
$65,183,000 |
